Siemens Healthcare has announced the appointment of Gregory Sorensen, MD, as CEO of Siemens Healthcare in the U.S., effective June 1. Sorensen succeeds Randy Hill, who had served as interim CEO.
In his new position, Sorensen will lead the marketing, sales, service, and support functions for Siemens Healthcare, as well as oversee the company’s Canadian activities. His scope of responsibility in the U.S. will extend across the entire health care portfolio, including medical imaging, therapy, healthcare information technology, and laboratory diagnostics. Sorensen will be based at Siemens Healthcare’s U.S. headquarters in Malvern, Pennsylvania.
Sorensen is a practicing neuroradiologist and active researcher with significant experience in clinical care, clinical trials, and translational research. His research and techniques are utilized by centers throughout the world in phase II and III trials of such novel oncology agents as gene therapy. He currently serves as a professor of radiology and health sciences and technology at Harvard Medical School; faculty member of the Harvard-MIT Division of Health Sciences and Technology; and co-director of the A.A. Martinos Center for Biomedical Imaging at Massachusetts General Hospital (MGH).